Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
82,051,282
-
Total 13F shares
-
6,003,456
-
Share change
-
+912,825
-
Total reported value
-
$109,804,000
-
Price per share
-
$18.29
-
Number of holders
-
24
-
Value change
-
+$18,372,890
-
Number of buys
-
14
-
Number of sells
-
13
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) as of Q2 2021
As of 30 Jun 2021,
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,003,456 shares.
The largest 10 holders included
Ally Bridge Group (NY) LLC, PERCEPTIVE ADVISORS LLC, D. E. Shaw & Co., Inc., WELLINGTON MANAGEMENT GROUP LLP, Point72 Asset Management, L.P., VANGUARD GROUP INC, BVF INC/IL, Ghost Tree Capital, LLC, Cormorant Asset Management, LP, and RA CAPITAL MANAGEMENT, L.P..
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.